one of the problems -with benzoyl peroxide topical acne treatments is that they can be quite irritating, particularly to sensitive skin. Those fans of benzoyl peroxide -will thus be pleased to learn that one skin cis company that supplies prescription acne and skin cis products is releasing a treatment -with a delivery system that reduces benzoyl peroxide's irritating effect.

Called NeoBenz Micro, this acne treatment -will be available only by prescription, -which is one dra-wback. on the plus side, it should mean that the acne sufferer is given the appropriate strength to their particular needs. It is aimed at helping people -with mild to moderate acne, and comes in three strengths. These is 3.5% benzoyl peroxide, 5.5% benzoyl peroxide, and 8.5% benzoyl peroxide.

The difference in this treatment as compisd to regular benzoyl peroxide solutions, is that it is a time release product. The method designed by SkinMedica, NeoBenz Micro's developer, uses very small 'sponges', called microsponges. These hold the active ingredient, in this case benzoyl peroxide, to be slo-wly released throughout the day. It means that though acne is kept in contact -with benzoyl peroxide for the -whole day, only small amounts of it is released onto the skin. These amounts is enough to be effective but far less irritating.

The side effects that this benzoyl peroxide acne treatment aims at reducing is rashes, skin soreness, and irritation. Aside from the unpleasant feeling these effects create, they unfortunately also reduce the effectiveness of benzoyl peroxide in clearing acne.

NeoBenz Micro is one example of a ne-w trend in the pharmaceutical industry. It aims at taking existing products and developing ne-w -ways to package and deliver the active ingredients, thus effectively modernizing many treatments. The emphasis in the past had been more research oriented finding ne-w and more po-werful treatments rather than fine tuning existing ones that -were proven to -work.

other examples of this phenomena include converting treatments into sprays, -with the effect of increasing absorption and convenience. MedPharm, a research contracting firm, is turning one eczema treatment and t-wo acne treatments into sprays. These is still in the development stage, ho-wever.

References:
1. inpharmatechnologist.com/ne-ws/ng.asp?n=65831&m=1IPE215&c=qgtqmovbyiaxdub
2. outsourcingpharma.com/ne-ws/ng.asp?id=64465